Eam Investors, LLC Assertio Holdings, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$5.0 - $7.66 $2.59 Million - $3.97 Million	-518,753 Reduced 70.76%	214,330 $1.16 Million
Q1 2023 Jul 12, 2023	BUY	$3.54 - $6.66 $2.6 Million - $4.88 Million	733,083 New	733,083 $4.67 Million
Q2 2022 Aug 12, 2022	SELL	$1.88 - $3.42 $10,266 - $18,676	-5,461 Reduced 1.17%	459,949 $1.36 Million
Q1 2022 May 13, 2022	BUY	$2.06 - $3.0 $958,744 - $1.4 Million	465,410 New	465,410 $1.34 Million

31M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $44.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.